Amicus Therapeutics Inc
FOLD
Market Cap$2.05B
Close$
$12.62
107.6% upside
Current Fair Value
107.6% upsideUndervalued by 107.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.05 Billion |
|---|---|
| Enterprise Value | $2.26 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.18 |
| Beta | 0.79 |
| Outstanding Shares | 307,689,207 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -69.87 |
|---|---|
| PEG | 126.55 |
| Price to Sales | 6.08 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.17 |
| Enterprise Value to EBIT | -82.19 |
| Enterprise Value to Net Income | 58 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 2.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Amicus Therapeutics Inc
CEO: John Crowley